Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-01

Clinical Trial Update: Effects of Huperzine a on Presbycusis(Δ,kHz, DB,MMSE, AD) [NA]

View source ↗

Summary

Clinical trial evaluating the effects of Huperzine A on presbycusis, including tinnitus and cognitive impairment; currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Huperzine A (Huperzine A)

Snippet

Sponsor: Zhijun Bao | Conditions: Presbycusis, Tinnitus | NA | Status: ENROLLING_BY_INVITATION